0000891293-15-000037.txt : 20150925 0000891293-15-000037.hdr.sgml : 20150925 20150925164232 ACCESSION NUMBER: 0000891293-15-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150924 FILED AS OF DATE: 20150925 DATE AS OF CHANGE: 20150925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Plunkett Matthew CENTRAL INDEX KEY: 0001557551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151125555 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-09-24 0 0000891293 CTI BIOPHARMA CORP ctic 0001557551 Plunkett Matthew 3101 WESTERN AVENUE, SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Corporate Development Common Stock 2015-09-24 4 S 0 3600 1.52 D 797353 D Common Stock 2015-09-24 4 S 0 13201 1.525 D 784152 D Common Stock 2015-09-24 4 S 0 200 1.5275 D 783952 D Common Stock 2015-09-24 4 S 0 6899 1.53 D 777053 D Common Stock 2015-09-24 4 S 0 100 1.535 D 776953 D Common Stock 2015-09-24 4 S 0 289 1.54 D 776664 D Common Stock 2015-09-24 4 S 0 600 1.545 D 776064 D Common Stock 2015-09-24 4 S 0 800 1.55 D 775264 D Common Stock 2015-09-24 4 S 0 800 1.56 D 774464 D Common Stock 2015-09-24 4 S 0 1700 1.57 D 772764 D Common Stock 2015-09-24 4 S 0 1000 1.575 D 771764 D Common Stock 2015-09-24 4 S 0 5330 1.58 D 766434 D Common Stock 2015-09-24 4 S 0 7000 1.585 D 759434 D Common Stock 2015-09-24 4 S 0 16400 1.59 D 743034 D Common Stock 2015-09-24 4 S 0 1500 1.595 D 741534 D Common Stock 2015-09-24 4 S 0 14400 1.6 D 727134 D Common Stock 2015-09-24 4 S 0 1390 1.605 D 725744 D Common Stock 2015-09-24 4 S 0 660 1.61 D 725084 D The sale was effected pursuant to a Rule 10b5-1 trading plan. By: Louis A. Bianco, Attorney-in-fact For: Matthew Plunkett 2015-09-25